Difference between revisions of "Mianserine-mirtazapine"

From Psychiatrienet
Jump to: navigation, search
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
 
| to = mirtazapine  
 
| to = mirtazapine  
 
| stop =  
 
| stop =  
* '''Day 0:''' gradually reduce dosage of mianserine to a maximum of 60 mg/ day.
+
* '''Before day 1:''' gradually reduce dosage of mianserine to a maximum of 60 mg/ day.
 
* '''Day 1:''' reduce a dosage of 60 mg/day to 30 mg/day.
 
* '''Day 1:''' reduce a dosage of 60 mg/day to 30 mg/day.
 
| start =   
 
| start =   
Line 9: Line 9:
 
* '''Day 8:''' stop administration of mianserine and only continue administration of mirtazapine in a dosage of 30 mg/day.
 
* '''Day 8:''' stop administration of mianserine and only continue administration of mirtazapine in a dosage of 30 mg/day.
 
| info =  
 
| info =  
* Mirtazapine and mianserine do have a quite identical pharmacological profile.}}
+
* Mirtazapine and mianserine do have a quite identical antidepressive pharmacological profile.}}

Latest revision as of 15:11, 17 November 2009

Mianserine
Type Antidepressant
Group other
links
PubChem 4184
PubMed Mianserine
Kompas (Dutch) Mianserine
Wikipedia Mianserine
Mirtazapine
Type Antidepressant
Group other
links
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine

Switch medication from mianserine to mirtazapine.[1] [2]

Nietinrijdenbord.png Stop mianserine
  • Before day 1: gradually reduce dosage of mianserine to a maximum of 60 mg/ day.
  • Day 1: reduce a dosage of 60 mg/day to 30 mg/day.
Eenrichtingbord.png Start mirtazapine
  • Day 1: simultaneously start mirtazapine in a low dosage of 15 mg/day.
  • Day 8: stop administration of mianserine and only continue administration of mirtazapine in a dosage of 30 mg/day.
Infobord.png More information
  • Mirtazapine and mianserine do have a quite identical antidepressive pharmacological profile.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.